Literature DB >> 474149

Supersensitivity of the rat urinary bladder following "chemical sympathectomy".

J Ekström.   

Abstract

6-hydroxydopamine (100 mg/kg injected intravenously twice with a weekly interval) was used for the destruction of the adrenergic nerves in the rat detrusor muscle. Two to three weeks after the first injection of this substance the sensitivity of the detrusor muscle to parasympathomimetic and sympathomimetic drugs was tested by recording the intravesical pressure in situ. The sensitivity to methacholine was found to be unchanged, whereas a supersensitivity to noradrenaline, adrenaline, phenylephrine and isoprenaline was found to have developed, thus involving both alpha-adrenoceptor mediated contraction and beta-adrenoceptor mediated relaxation. The supersensitivity was of the postjunctional type.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 474149

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  4 in total

1.  Origin and distribution of neuropeptide Y-, vasoactive intestinal polypeptide-and substance P-containing nerve fibers in the urinary bladder of the rat.

Authors:  A Mattiasson; E Ekblad; F Sundler; B Uvelius
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

2.  Growth of sympathetic postganglionic axons after partial chemical destruction with guanethidine.

Authors:  I M Rodionov; V N Yarygin; A Mukhammedov; B N Manukhin; D B Lebedev; L A Nesterova
Journal:  Pflugers Arch       Date:  1981-12       Impact factor: 3.657

3.  Changes in sensitivity to the inhibitory effects of adrenergic agonists on intestinal motor activity after chronic sympathetic denervation.

Authors:  G M Frigo; S Lecchini; M Marcoli; M Tonini; L D'Angelo; A Crema
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-02       Impact factor: 3.000

4.  Local Change in Urinary Bladder Contractility Following CNS Dopamine Denervation in the 6-OHDA Rat Model of Parkinson's Disease.

Authors:  Reinika Mitra; Patrik Aronsson; Michael Winder; Gunnar Tobin; Filip Bergquist; Thomas Carlsson
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.